NCI Wins $87M Recompete of CERT Program for CMS

Loading...
Loading...
RESTON, Va.--(BUSINESS WIRE)--

NCI, Inc. NCIT, a leading provider of information technology (IT) and professional services and solutions to U.S. Federal Government agencies, announced today that it was awarded an $87 million firm-fixed-price contract with the Centers for Medicare and Medicaid Services (CMS). The contract continues support of CMS' Comprehensive Error Rate Testing (CERT) program by NCI and its wholly-owned subsidiary AdvanceMed. The expanded scope of work includes request and receipt of medical documentation for Medicare claims billed and call center support. The award consists of a one-year base period and four one-year option periods.

CMS developed the CERT program to calculate the Medicare Fee-for-Service (FFS) program's improper payment rate using a sample of claims from the Medicare claims universe to determine whether the claims have been paid properly based on Medicare coverage, coding and billing rules. NCI will utilize the innovative medical review tracking, reviewing and reporting system it built for CMS, CERT360, which integrates and controls all aspects of the CERT program's medical review activity. The system's advanced three-tier design incorporates best practices compiled from managing and successfully completing more than 1.5 million Medicare medical review audits for CMS.

NCI will work with billing and ordering providers to receive and process medical records for purposes of conducting medical reviews. The company also will provide customer service support to the Medicare Administrative Contractors (MACs) and providers that have claims sampled for review. It will conduct medical reviews on claims sampled for CERT and other CMS accuracy reviews; communicate results; and maintain various websites for internal and external stakeholders. NCI's expanded role incorporates the request and receipt of medical records associated with these claims and provides a "one-stop shop" for MACs, providers and others for CMS continuity of services.

NCI also will provide the data from the review of these claims to CMS for the agency's use in submitting the National Medicare FFS program's improper payment rate to the U.S. Congress and to publicly report the findings and actions CMS is taking to reduce improper payments.

"NCI reviews an average of 50,000 medical claims per year under the CERT program, in order for CMS to statistically determine the improper payment rate for the Medicare FFS program," said Brian J. Clark, NCI's president and CEO. "We are proud to continue our work on this important program serving CMS, one of our largest and longest-standing customers. Our CERT team has delivered superior results over the past 16 years while bringing innovative technology to enhance outcomes for CMS."

About NCI, Inc.:

NCI is a leading provider of enterprise solutions and services to U.S. defense, intelligence, health and civilian government agencies. The company has the expertise and proven track record to solve its customers' most important and complex mission challenges through technology and innovation. NCI's team of highly skilled professionals focuses on delivering cost-effective solutions and services in the areas of agile development and integration; cybersecurity and information assurance; engineering and logistics; big data and data analytics; IT infrastructure optimization and service management; and health and program integrity. Headquartered in Reston, Virginia, NCI has approximately 2,000 employees operating at more than 100 locations worldwide. For more information, visit www.nciinc.com or email investor@nciinc.com. Like us on Facebook and follow us on Twitter (@nciinc_) and LinkedIn.

NCI, Inc.
IR Contact
Lawrence Delaney, Jr.
Investor Relations Advisor
714-734-5142
or
Media Contact
Joelle Shreves
Vice President of Marketing & Corporate Communications
703-707-6904

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...